SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Felix B who wrote (2009)1/14/2017 1:57:21 AM
From: Miljenko Zuanic  Respond to of 3559
 
They can extend for 3 more years on two specified targets with R&D call for those targets, general antibody research collaboration end. I/O continue. Hope they will end their general antibody call and move by their own path forward. Spending $720M on facilities/land indicate that they are going big independent!